for the treatment for thyroid eye disease (TED). ACELYRIN recently completed a positive end of Phase 2 (EOP2) interaction with the U.S. Food and Drug Administration (FDA), achieving alignment on ...
In general, effects of hypothyroidism can be reversed with replacement doses of thyroid hormone. Other human trials involved triac (triiodo-thyroacetic acid), a natural thyroid hormone analogue ...